Barrier Therapeutics, Inc. - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Barrier Therapeutics, Inc.. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Barrier Therapeutics, Inc.. The Group's principal activity is the discovery, development and commercialization of a portfolio of innovative pharmaceutical products to address major medical needs in the field of dermatology. Currently it has multiple product candidates in clinical development, with four of these candidates in or entering Phase III clinical trials. Its advanced product candidates are Sebazole, Zimycan, Hyphanox and Liarozole. Its trademarks are Barrier TherapeuticsTM, SebazoleTM, ZimycanTM, HyphanoxTM, RambazoleTM and HivenylTM. The Group operates in the United States.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report